Triumph Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Triumph Capital Management's EW Position: Q3 2026 in Review
Triumph Capital Management held its Edwards Lifesciences (EW) position steady in Q3 2026 at 13 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1687.
Triumph Capital Management first reported a position in EW in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.18K in Q2 2026. 1,206 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Triumph Capital Management held 13 shares of Edwards Lifesciences worth $1.12K as of Q3 2026.
- Triumph Capital Management left its Edwards Lifesciences share count unchanged in Q3 2026.
- Edwards Lifesciences made up ﹤0.01% of Triumph Capital Management's portfolio in Q3 2026, its #1687 holding.
- Triumph Capital Management first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 4 quarters since.
- Triumph Capital Management's Edwards Lifesciences position peaked at $1.18K in Q2 2026.
- 1,206 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Triumph Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.